Botanical species · safety record

Dipsacus japonicus

The EFSA Compendium of Botanicals holds 3 constituent measurements for Dipsacus japonicus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Dipsacus japonicus Miq.

3Constituent measurements

0Safety records

2Cited sources

6Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 6 licensed products naming Dipsacus japonicus as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

decoction

Source material stated

Root

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
1,8-cineole	Flowering top	Essential oil	7.91 Percent	GC-MS	No resolvable identifier
Carvone	Flowering top	Essential oil	1.38 Percent	GC-MS	No resolvable identifier
Triterpene saponins	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Liu, Zhi Long., Jiang, Guo Hua., Zhou, Ligang., Liu, Qi Zhi. Analysis of the Essential Oil of Dipsacus japonicus Flowering Aerial Parts and its Insecticidal Activity against Sitophilus zeamais and Tribolium castaneum . Zeitschrift fur naturforschung section c-a journal of biosciences, 2013, vol. 68, no. 1-2, p. 13-18.
Trinh, Thi Thuy., Tran, Van Sung., Adam, Guenter. Study on chemical constituents of Dipsacus japonicus. II. Triterpene glycosides. Tap chi hoa hoc, 2002, p. 13-19.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature